Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial

BACKGROUND: Health‐related quality of life (HRQL) is often diminished in patients with ulcerative colitis. AIM: To evaluate the effects of vedolizumab on HRQL in patients with ulcerative colitis. METHODS: Using maintenance phase data from the GEMINI 1 study, an analysis of covariance model was used...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Aliment Pharmacol Ther
Auteurs principaux: Feagan, B. G., Patel, H., Colombel, J.‐F., Rubin, D. T., James, A., Mody, R., Lasch, K.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Inflammatory Bowel Disease
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215718/
https://ncbi.nlm.nih.gov/pubmed/27859410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13852
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires